Allan Bradley

Allan Bradley is currently the Chief Executive Officer at T-Therapeutics Ltd and the Co-Founder of ExpressionEdits. Previously, Allan was the Co-founder, Director, and Chief Scientific Officer at PetMedix. Allan has also held roles such as Founder, Director, and Chief Scientific Officer at Kymab Ltd and Senior Group Leader at the Wellcome Trust Sanger Institute. With a background in Genetics, Allan has made significant contributions in the field of research and biotechnology throughout their career.